- Home
- PGEN vs AEF Comparison
PGEN vs AEF Comparison
Compare PGEN & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- AEF
- Stock Information
- Founded
- PGEN 1998
- AEF 1989
- Country
- PGEN United States
- AEF United States
- Employees
- PGEN N/A
- AEF N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- AEF Finance/Investors Services
- Sector
- PGEN Health Care
- AEF Finance
- Exchange
- PGEN Nasdaq
- AEF Nasdaq
- Market Cap
- PGEN 404.4M
- AEF 196.1M
- IPO Year
- PGEN N/A
- AEF N/A
- Fundamental
- Price
- PGEN $1.42
- AEF $5.94
- Analyst Decision
- PGEN Strong Buy
- AEF
- Analyst Count
- PGEN 3
- AEF 0
- Target Price
- PGEN $6.00
- AEF N/A
- AVG Volume (30 Days)
- PGEN 1.8M
- AEF 92.5K
- Earning Date
- PGEN 08-13-2025
- AEF 01-01-0001
- Dividend Yield
- PGEN N/A
- AEF 7.13%
- EPS Growth
- PGEN N/A
- AEF N/A
- EPS
- PGEN N/A
- AEF 0.57
- Revenue
- PGEN $4,201,000.00
- AEF N/A
- Revenue This Year
- PGEN $158.57
- AEF N/A
- Revenue Next Year
- PGEN $1,086.91
- AEF N/A
- P/E Ratio
- PGEN N/A
- AEF $8.86
- Revenue Growth
- PGEN N/A
- AEF N/A
- 52 Week Low
- PGEN $0.65
- AEF $4.40
- 52 Week High
- PGEN $2.17
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- PGEN 47.78
- AEF 67.14
- Support Level
- PGEN $1.38
- AEF $5.51
- Resistance Level
- PGEN $1.55
- AEF $5.77
- Average True Range (ATR)
- PGEN 0.09
- AEF 0.08
- MACD
- PGEN -0.01
- AEF 0.00
- Stochastic Oscillator
- PGEN 17.39
- AEF 95.00
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.